Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients

NCT02121717 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

535

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Chiglitazar
DRUG: Placebo

Sponsor

Chipscreen Biosciences, Ltd.